|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 123 JPY | 0.00% |
|
-3.15% | -8.89% |
| Apr. 01 | Chiome Bioscience Cancels License Agreements with ADC Therapeutics | MT |
| Feb. 13 | Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited | CI |
Chiome Bioscience Inc. announced that they have resolved to enter into an entrustment agreement with Takeda Pharmaceutical Company Limited for antibody generation using the ADLib system, antibody generation technology. They have had entered into a separate outsourcing agreement with Takeda to conduct antibody generation, etc. using the ADLib® System.
By entering into the Entrusment Agreement, they will be able to provide research support services rapidly to Takeda, such as antibody production.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 4,089 JPY | -0.02% | +0.49% | 40.76B | ||
| 123 JPY | 0.00% | -3.15% | 43.53M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -8.89% | 43.53M | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
CHIOME BIOSCIENCE INC. 
